loading

Biodexa Pharmaceuticals Plc ADR (BDRX) 最新ニュース

Posting of Annual Report & Notice of AGM - Total Voting Rights

pulisher
GlobeNewswire Inc.

Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting

pulisher
GlobeNewswire Inc.

12 ChatGPT Penny Stock Picks Right Now - Insider Monkey

pulisher
Insider Monkey

12 ChatGPT Penny Stock Picks Right Now - Insider Monkey

pulisher
Insider Monkey

MSN - MSN

pulisher
MSN

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

pulisher
GlobeNewswire Inc.

Preliminary Results for the Year Ended 31 December 2023

pulisher
GlobeNewswire Inc.

Here’s How Global Events Impact Penny Stocks

pulisher
PennyStocks

Is Market Cap an Important Penny Stocks Trading Factor?

pulisher
PennyStocks

Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results

pulisher
Benzinga

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Gold Gains 1%; Walgreens Narrows Earnings Forecast

pulisher
Benzinga

US Stocks Flat; Initial Jobless Claims Fall To 210,000

pulisher
Benzinga

Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update

pulisher
GlobeNewswire Inc.

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients

pulisher
GlobeNewswire Inc.

Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024

pulisher
GlobeNewswire Inc.

Biodexa Appoints Ann Merchant to the Board of Directors

pulisher
GlobeNewswire Inc.

Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option

pulisher
GlobeNewswire Inc.

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge

pulisher
Benzinga

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results

pulisher
Benzinga

Biodexa Announces Pricing of $5.2 Million Underwritten Public Offering

pulisher
GlobeNewswire Inc.

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

What's Going On With Biodexa Pharmaceuticals Stock (BDRX) Today? - Biodexa Pharmaceuticals (NASDAQ:BDRX) - Benzinga

pulisher
Benzinga

Crude Oil Falls; RedHill Biopharma Shares Spike Higher

pulisher
Benzinga

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

Nasdaq Moves Higher; US New Home Sales Fall In October

pulisher
Benzinga

US Stocks Lower; Dow Falls Over 50 Points

pulisher
Benzinga

Biodexa Pharmaceuticals will rise 8,000% at the open - Dhaka Tribune

pulisher
Dhaka Tribune
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
大文字化:     |  ボリューム (24 時間):